FDA to Ban Most Flavored Electronic Cigarettes

2018-11-13 04:59:52
As part of the U.S. Food and Drug Administration's efforts to reduce teens' use of flavored electronic cigarettes, a ban on sales of most flavored e-cigarettes in retail stores and gas stations across the United States is to be introduced, according...

FDA to Ban Most Flavored Electronic Cigarettes

2018-11-13 04:57:53
As part of the U.S. Food and Drug Administration's efforts to reduce teens' use of flavored electronic cigarettes, a ban on sales of most flavored e-cigarettes in retail stores and gas stations across the United States is to be introduced, according...

VITAL: No CVD or Cancer Benefit From Vitamin D, Omega-3

2018-11-12 03:36:41
CHICAGO — More research is showing no significant benefit from vitamin D supplementation for the prevention of cardiovascular disease (CVD) or cancer — and little benefit from omega-3 supplements, as both therapies missed their primary...

New Drugs Under Development( Not Approved Yet)

2018-11-11 13:26:10
1. Generic name: larotrectinibCompany: Loxo Oncology, Inc.Treatment for: Solid TumorsLarotrectinib is an oral selective tropomyosin receptor kinase (TRK) inhibitor in clinical development for the treatment solid tumors harboring NTRK-fusion...

FDA Clears First Ebola Fingerstick Test With Portable Reader

2018-11-10 13:01:49
The US Food and Drug Administration (FDA) has granted emergency use of a new rapid antigen fingerstick test to detect Ebola virus.The DPP Ebola Antigen System (Chembio Diagnostic Systems Inc) is the second Ebola rapid antigen fingerstick te...

FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD)

2018-11-10 12:57:02
November 09, 2018 -- Today, the U.S. Food and Drug Administration (FDA) approved Yupelri (revefenacin) Inhalation Solution for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Revefenacin is a long-acting musca...

Check Drug Interactions in Medicomarket App

2018-11-10 09:43:15
Dear Professionals, we have posted above 17000 Drug interactions, Much more information to come, Stay connected

Medherant completes two phase I studies with novel Ibuprofen TEPI Patch

2018-11-10 09:40:57
Medherant, a developer of innovative transdermal drug delivery treatments for pain and CNS diseases, has successfully completed two phase I studies with its novel Ibuprofen TEPI Patch.  The TEPI Patch was shown to be well tolerated by all subjec...

NeoTract receives Japanese approval for UroLift System to treat benign prostatic hyperplasia

2018-11-10 08:19:45
NeoTract, a wholly owned subsidiary of Teleflex Incorporated focused on addressing unmet needs in the field of urology, has received Shonin approval from the Ministry of Health, Labor and Welfare (MHLW) in Japan for the UroLift System for the treatme...

FDA Approves Newly Formulated OTC Primatene Mist (epinephrine) to Treat Mild Asthma

2018-11-09 13:50:52
Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced today that the U.S. Food and Drug Administration (FDA) granted approval of its New Drug Application (NDA) for Primatene Mist (epinephrine inhalation aerosol bronchodilator suspension), which i...